{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:44:22Z","timestamp":1790419462779,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Cardiovasc Med"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s11936-008-0053-6","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T06:57:47Z","timestamp":1269932267000},"page":"329-341","source":"Crossref","is-referenced-by-count":22,"title":["Right-sided heart failure: Diagnosis and treatment strategies"],"prefix":"10.1007","volume":"10","author":[{"given":"Jennifer Cowger","family":"Matthews","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd F.","family":"Dardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Dorsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith D.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"53_CR1","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/000331970505600402","volume":"56","author":"A. Chockalingam","year":"2005","unstructured":"Chockalingam A, Gnanavelu G, Subramaniam T, et al.: Right ventricular myocardial infarction: presentation and acute outcomes. Angiology 2005, 56:371\u2013376.","journal-title":"Angiology"},{"key":"53_CR2","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1016\/j.clinthera.2007.10.009","volume":"29","author":"N. Benedict","year":"2007","unstructured":"Benedict N, Seybert A, Mathier MA: Evidence-based pharmacologic management of pulmonary arterial hypertension. Clin Ther 2007, 29:2134\u20132153.","journal-title":"Clin Ther"},{"key":"53_CR3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.cell.2006.09.003","volume":"126","author":"D. Srivastava","year":"2006","unstructured":"Srivastava D: Making or breaking the heart: from lineage determination to morphogenesis. Cell 2006, 126:1037\u20131048.","journal-title":"Cell"},{"key":"53_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.107.162206","volume":"101","author":"B.S. Snarr","year":"2007","unstructured":"Snarr BS, O\u2019Neal JL, Chintalapudi MR, et al.: Isl1 expression at the venous pole identifies a novel role for the second heart field in cardiac development. Circ Res 2007, 101:971\u2013974.","journal-title":"Circ Res"},{"key":"53_CR5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nrg1710","volume":"6","author":"M. Buckingham","year":"2005","unstructured":"Buckingham M, Meilhac S, Zaffran S: Building the mammalian heart from two sources of myocardial cells. Nat Rev Genet 2005, 6:826\u2013835.","journal-title":"Nat Rev Genet"},{"key":"53_CR6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1534-5807(03)00363-0","volume":"5","author":"C.L. Cai","year":"2003","unstructured":"Cai CL, Liang X, Shi Y, et al.: Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell 2003, 5:877\u2013889.","journal-title":"Dev Cell"},{"key":"53_CR7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00019501-200502000-00003","volume":"16","author":"K.M. Chin","year":"2005","unstructured":"Chin KM, Kim NH, Rubin LJ: The right ventricle in pulmonary hypertension. Coron Artery Dis 2005, 16:13\u201318.","journal-title":"Coron Artery Dis"},{"key":"53_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00134-003-2025-3","volume":"30","author":"A. Mebazaa","year":"2004","unstructured":"Mebazaa A, Karpati P, Renaud E, Algotsson L: Acute right ventricular failure\u2014from pathophysiology to new treatments. Intensive Care Med 2004, 30:185\u2013196.","journal-title":"Intensive Care Med"},{"key":"53_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1113\/jphysiol.2005.101428","volume":"571","author":"R.P. Kondo","year":"2006","unstructured":"Kondo RP: Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol 2006, 571:131.","journal-title":"J Physiol"},{"key":"53_CR10","doi-asserted-by":"crossref","first-page":"H2013","DOI":"10.1152\/ajpheart.00167.2006","volume":"291","author":"G.Y. Wang","year":"2006","unstructured":"Wang GY, McCloskey DT, Turcato S, et al.: Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol 2006, 291:H2013\u2013H2017.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"53_CR11","doi-asserted-by":"crossref","first-page":"R1893","DOI":"10.1152\/ajpregu.00359.2007","volume":"293","author":"T.A. Markel","year":"2007","unstructured":"Markel TA, Crisostomo PR, Wang M, et al.: Right ventricular TNF resistance during endotoxemia: the differential effects on ventricular function. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1893\u2013R1897.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"53_CR12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0002-8703(97)70230-8","volume":"133","author":"P.K. Ganguly","year":"1997","unstructured":"Ganguly PK, Dhalla KS, Shao Q, et al.: Differential changes in sympathetic activity in left and right ventricles in congestive heart failure after myocardial infarction. Am Heart J 1997, 133:340\u2013345.","journal-title":"Am Heart J"},{"key":"53_CR13","first-page":"H884","volume":"272","author":"R. Sethi","year":"1997","unstructured":"Sethi R, Dhalla KS, Beamish RE, Dhalla NS: Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol 1997, 272:H884\u2013H893.","journal-title":"Am J Physiol"},{"key":"53_CR14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1161\/01.HYP.26.1.78","volume":"26","author":"F.L. Atkins","year":"1995","unstructured":"Atkins FL, Bing OH, DiMauro PG, et al.: Modulation of left and right ventricular beta-adrenergic receptors from spontaneously hypertensive rats with left ventricular hypertrophy and failure. Hypertension 1995, 26:78\u201382.","journal-title":"Hypertension"},{"key":"53_CR15","first-page":"H868","volume":"262","author":"N. Afzal","year":"1992","unstructured":"Afzal N, Dhalla NS: Differential changes in left and right ventricular SR calcium transport in congestive heart failure. Am J Physiol 1992, 262:H868\u2013H874.","journal-title":"Am J Physiol"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ejphar.2005.08.031","volume":"522","author":"M. Takahashi","year":"2005","unstructured":"Takahashi M, Tanonaka K, Yoshida H, et al.: Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation. Eur J Pharmacol 2005, 522:84\u201393.","journal-title":"Eur J Pharmacol"},{"key":"53_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1183\/09031936.00124207","volume":"31","author":"R. Faludi","year":"2008","unstructured":"Faludi R, Komocsi A, Bozo J, et al.: Isolated diastolic dysfunction of right ventricle: stress-induced pulmonary hypertension. Eur Respir J 2008, 31:475\u2013476.","journal-title":"Eur Respir J"},{"key":"53_CR18","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000085369","volume":"72","author":"N. Dursunoglu","year":"2005","unstructured":"Dursunoglu N, Dursunoglu D, Kilic M: Impact of obstructive sleep apnea on right ventricular global function: sleep apnea and myocardial performance index. Respiration 2005, 72:278\u2013284.","journal-title":"Respiration"},{"key":"53_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/hc2901.093198","volume":"104","author":"X.G. Sun","year":"2001","unstructured":"Sun XG, Hansen JE, Oudiz RJ, Wasserman K: Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001, 104:429\u2013435.","journal-title":"Circulation"},{"key":"53_CR20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.0742-2822.2004.03139.x","volume":"21","author":"A. Chockalingam","year":"2004","unstructured":"Chockalingam A: Myocardial performance index in evaluation of acute right ventricular myocardial infarction. Echocardiography 2004, 21:487\u2013494.","journal-title":"Echocardiography"},{"key":"53_CR21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.echo.2005.02.004","volume":"18","author":"J. Meluzin","year":"2005","unstructured":"Meluzin J, Spinarova L, Hude P, et al.: Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure. J Am Soc Echocardiogr 2005, 18:435\u2013444.","journal-title":"J Am Soc Echocardiogr"},{"key":"53_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1067\/mje.2001.111478","volume":"14","author":"J.E. M\u00f8ller","year":"2001","unstructured":"M\u00f8ller JE, Sondergaard E, Poulsen SH, et al.: Serial Doppler echocardiographic assessment of left and right ventricular performance after a first myocardial infarction. J Am Soc Echocardiogr 2001, 14:249\u2013255.","journal-title":"J Am Soc Echocardiogr"},{"key":"53_CR23","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1378\/chest.07-0966","volume":"132","author":"A. Romero-Corral","year":"2007","unstructured":"Romero-Corral A, Somers VK, Pellikka PA, et al.: Decreased right and left ventricular myocardial performance in obstructive sleep apnea. Chest 2007, 132:1863\u20131870.","journal-title":"Chest"},{"key":"53_CR24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1540-8175.2007.00430.x","volume":"24","author":"S. Gondi","year":"2007","unstructured":"Gondi S, Dokainish H: Right ventricular tissue Doppler and strain imaging: ready for clinical use? Echocardiography 2007, 24:522\u2013532.","journal-title":"Echocardiography"},{"key":"53_CR25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jacc.2005.11.015","volume":"47","author":"C.Y. Wong","year":"2006","unstructured":"Wong CY, O\u2019Moore-Sullivan T, Leano R, et al.: Association of subclinical right ventricular dysfunction with obesity. J Am Coll Cardiol 2006, 47:611\u2013616.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1525-2167(02)00171-3","volume":"4","author":"J. Meluzin","year":"2003","unstructured":"Meluzin J, Spinarova L, Dusek L, et al.: Prognostic importance of the right ventricular function assessed by Doppler tissue imaging. Eur J Echocardiogr 2003, 4:262\u2013271.","journal-title":"Eur J Echocardiogr"},{"key":"53_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejheart.2004.07.017","volume":"7","author":"L. Spinarova","year":"2005","unstructured":"Spinarova L, Meluzin J, Toman J, et al.: Right ventricular dysfunction in chronic heart failure patients. Eur J Heart Fail 2005, 7:485\u2013489.","journal-title":"Eur J Heart Fail"},{"key":"53_CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1067\/mje.2002.115773","volume":"15","author":"H. Kanzaki","year":"2002","unstructured":"Kanzaki H, Nakatani S, Kawada T, et al.: Right ventricular dP\/dt\/P(max), not dP\/dt(max), noninvasively derived from tricuspid regurgitation velocity is a useful index of right ventricular contractility. J Am Soc Echocardiogr 2002, 15:136\u2013142.","journal-title":"J Am Soc Echocardiogr"},{"key":"53_CR29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2005.08.022","volume":"46","author":"S.A. Hunt","year":"2005","unstructured":"Hunt SA: ACC\/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2005, 46:e1\u2013e82.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR30","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/CIRCULATIONAHA.106.632208","volume":"114","author":"N.F. Voelkel","year":"2006","unstructured":"Voelkel NF, Quaife RA, Leinwand LA, et al.: Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114:1883\u20131891.","journal-title":"Circulation"},{"key":"53_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejheart.2004.08.001","volume":"7","author":"P.J. Cowburn","year":"2005","unstructured":"Cowburn PJ, Cleland JG, McDonagh TA, et al.: Comparison of selective ET(A) and ET(B) receptor antagonists in patients with chronic heart failure. Eur J Heart Fail 2005, 7:37\u201342.","journal-title":"Eur J Heart Fail"},{"key":"53_CR32","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/hrt.2004.053991","volume":"91","author":"T. Attina","year":"2005","unstructured":"Attina T, Camidge R, Newby DE, Webb DJ: Endothelin antagonism in pulmonary hypertension, heart failure, and beyond. Heart 2005, 91:825\u2013831.","journal-title":"Heart"},{"key":"53_CR33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0735-1097(95)00399-1","volume":"26","author":"M. Nootens","year":"1995","unstructured":"Nootens M, Kaufmann E, Rector T, et al.: Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995, 26:1581\u20131585.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/157340308783565384","volume":"4","author":"J.C. Matthews","year":"2008","unstructured":"Matthews JC, McLaughlin VV: Acute right ventricular failure in the setting of acute pulmonary embolism or chronic pulmonary hypertension: a detailed review of the pathophysiology, diagnosis, and management. Curr Cardiol Rev 2008, 4:49\u201359.","journal-title":"Curr Cardiol Rev"},{"key":"53_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1183\/09031936.04.00028404","volume":"24","author":"M. Humbert","year":"2004","unstructured":"Humbert M, Barst RJ, Robbins IM, et al.: Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2. Eur Respir J 2004, 24:353\u2013359.","journal-title":"Eur Respir J"},{"key":"53_CR36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","volume":"358","author":"R.N. Channick","year":"2001","unstructured":"Channick RN, Simonneau G, Sitbon O, et al.: Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 2001, 358:1119\u20131123.","journal-title":"Lancet"},{"key":"53_CR37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1388-9842(03)00111-9","volume":"5","author":"A.P. Coletta","year":"2003","unstructured":"Coletta AP, Clark AL, Seymour AM, Cleland JG: Clinical trials update from the European Society of Cardiology Heart Failure meeting: COMET, COMPANION, Tezosentan and SHAPE. Eur J Heart Fail 2003, 5:545\u2013548.","journal-title":"Eur J Heart Fail"},{"key":"53_CR38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0735-1097(02)02708-0","volume":"41","author":"E. Kaluski","year":"2003","unstructured":"Kaluski E, Kobrin I, Zimlichman R, et al.: RITZ-5: randomized intravenous TeZosentan (an endothelin-A\/B antagonist) for the treatment of pulmonary edema: a prospective, multicenter, double-blind, placebo-controlled study. J Am Coll Cardiol 2003, 41:204\u2013210.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR39","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1001\/jama.298.17.2009","volume":"298","author":"J.J. McMurray","year":"2007","unstructured":"McMurray JJ, Teerlink JR, Cotter G, et al.: Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 2007, 298:2009\u20132019.","journal-title":"JAMA"},{"key":"53_CR40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/hrt.2006.089250","volume":"93","author":"N.F. Kelland","year":"2007","unstructured":"Kelland NF, Webb DJ: Clinical trials of endothelin antagonists in heart failure: publication is good for the public health. Heart 2007, 93:2\u20134.","journal-title":"Heart"},{"key":"53_CR41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1388-9842(01)00149-0","volume":"3","author":"A. Louis","year":"2001","unstructured":"Louis A, Cleland JG, Crabbe S, et al.: Clinical trials update: CAPRICORN, COPERNICUS, MIRACLE, STAF, RITZ-2, RECOVER and RENAISSANCE and cachexia and cholesterol in heart failure. Highlights of the Scientific Sessions of the American College of Cardiology, 2001. Eur J Heart Fail 2001; 3:381\u2013387.","journal-title":"Eur J Heart Fail"},{"key":"53_CR42","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1388-9842(01)00210-0","volume":"3","author":"A.P. Coletta","year":"2001","unstructured":"Coletta AP, Cleland JG: Clinical trials update: highlights of the scientific sessions of the XXIII Congress of the European Society of Cardiology\u2014WARIS II, ESCAMI, PAFAC, RITZ-1 and TIME. Eur J Heart Fail 2001, 3:747\u2013750.","journal-title":"Eur J Heart Fail"},{"key":"53_CR43","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/hrt.2004.040386","volume":"91","author":"S.J. Leslie","year":"2005","unstructured":"Leslie SJ, Spratt JC, McKee SP, et al.: Direct comparison of selective endothelin A and non-selective endothelin A\/B receptor blockade in chronic heart failure. Heart 2005, 91:914\u2013919.","journal-title":"Heart"},{"key":"53_CR44","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1345\/aph.1G254","volume":"41","author":"E.T. Wittbrodt","year":"2007","unstructured":"Wittbrodt ET, Abubakar A: Sitaxsentan for treatment of pulmonary hypertension. Ann Pharmacother 2007, 41:100\u2013105.","journal-title":"Ann Pharmacother"},{"key":"53_CR45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1742-1241.2006.01222.x","volume":"61","author":"R. Souza","year":"2007","unstructured":"Souza R, Martins BC, Jardim C, et al.: Effect of sitaxsentan treatment on quality of life in pulmonary arterial hypertension. Int J Clin Pract 2007, 61:153\u2013156.","journal-title":"Int J Clin Pract"},{"key":"53_CR46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","volume":"364","author":"I. Anand","year":"2004","unstructured":"Anand I, McMurray J, Cohn JN, et al.: Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial. Lancet 2004, 364:347\u2013354.","journal-title":"Lancet"},{"key":"53_CR47","first-page":"696","volume":"231","author":"N.F. Kelland","year":"2006","unstructured":"Kelland NF, Webb DJ: Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) 2006, 231:696\u2013699.","journal-title":"Exp Biol Med (Maywood)"},{"key":"53_CR48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/0735-1097(92)90050-W","volume":"19","author":"A. Costard-Jackle","year":"1992","unstructured":"Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 1992, 19:48\u201354.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR49","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.transproceed.2006.08.074","volume":"38","author":"M.V. Mogollon","year":"2006","unstructured":"Mogollon MV, Lage E, Cabezon S, et al.: Combination therapy with sildenafil and bosentan reverts severe pulmonary hypertension and allows heart transplantation: case report. Transplant Proc 2006, 38:2522\u20132523.","journal-title":"Transplant Proc"},{"key":"53_CR50","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","volume":"287","author":"M.S. Cuffe","year":"2002","unstructured":"Cuffe MS, Califf RM, Adams KF Jr, et al.: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541\u20131547.","journal-title":"JAMA"},{"key":"53_CR51","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1056\/NEJM199111213252103","volume":"325","author":"M. Packer","year":"1991","unstructured":"Packer M, Carver JR, Rodeheffer RJ, et al.: Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991, 325:1468\u20131475.","journal-title":"N Engl J Med"},{"key":"53_CR52","doi-asserted-by":"crossref","first-page":"47M","DOI":"10.1016\/j.amjcard.2005.10.005","volume":"96","author":"M.D. Patel","year":"2005","unstructured":"Patel MD, Katz SD: Phosphodiesterase 5 inhibition in chronic heart failure and pulmonary hypertension. Am J Cardiol 2005, 96:47M\u201351M.","journal-title":"Am J Cardiol"},{"key":"53_CR53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","volume":"115","author":"G.D. Lewis","year":"2007","unstructured":"Lewis GD, Lachmann J, Camuso J, et al.: Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 2007, 115:59\u201366.","journal-title":"Circulation"},{"key":"53_CR54","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/CIRCULATIONAHA.107.716373","volume":"116","author":"G.D. Lewis","year":"2007","unstructured":"Lewis GD, Shah R, Shahzad K, et al.: Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension. Circulation 2007, 116:1555\u20131562.","journal-title":"Circulation"},{"key":"53_CR55","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/j.jacc.2007.07.078","volume":"50","author":"M. Guazzi","year":"2007","unstructured":"Guazzi M, Samaja M, Arena R, et al.: Long-term use of sildenafil in the therapeutic management of heart failure. J Am Coll Cardiol 2007, 50:2136\u20132144.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10072-003-0102-6","volume":"24","author":"C. Gandolfo","year":"2003","unstructured":"Gandolfo C, Sugo A, Del Sette M: Sildenafil and transient global amnesia. Neurol Sci 2003, 24:145\u2013146.","journal-title":"Neurol Sci"},{"key":"53_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00041327-200503000-00003","volume":"25","author":"H.D. Pomeranz","year":"2005","unstructured":"Pomeranz HD, Bhavsar AR: Nonarteritic ischemic optic neuropathy developing soon after use of sildenafil (Viagra): a report of seven new cases. J Neuroophthalmol 2005, 25:9\u201313.","journal-title":"J Neuroophthalmol"},{"key":"53_CR58","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.transproceed.2007.08.069","volume":"39","author":"M. Zakliczynski","year":"2007","unstructured":"Zakliczynski M, Maruszewski M, Pyka L, et al.: Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates. Transplant Proc 2007, 39:2856\u20132858.","journal-title":"Transplant Proc"},{"key":"53_CR59","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ejheart.2007.01.008","volume":"9","author":"A. Jabbour","year":"2007","unstructured":"Jabbour A, Keogh A, Hayward C, Macdonald P: Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation. Eur J Heart Fail 2007, 9:674\u2013677.","journal-title":"Eur J Heart Fail"},{"key":"53_CR60","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/01.CIR.0000061757.12581.15","volume":"107","author":"T.D. Bradley","year":"2003","unstructured":"Bradley TD, Floras JS: Sleep apnea and heart failure: part I: obstructive sleep apnea. Circulation 2003, 107:1671\u20131678.","journal-title":"Circulation"},{"key":"53_CR61","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1161\/01.CIR.0000061758.05044.64","volume":"107","author":"T.D. Bradley","year":"2003","unstructured":"Bradley TD, Floras JS: Sleep apnea and heart failure: part II: central sleep apnea. Circulation 2003, 107:1822\u20131826.","journal-title":"Circulation"},{"key":"53_CR62","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1164\/rccm.200511-1745PP","volume":"173","author":"M. Arzt","year":"2006","unstructured":"Arzt M, Bradley TD: Treatment of sleep apnea in heart failure. Am J Respir Crit Care Med 2006, 173:1300\u20131308.","journal-title":"Am J Respir Crit Care Med"},{"key":"53_CR63","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.cardfail.2007.02.003","volume":"13","author":"A.C. Chwan Ng","year":"2007","unstructured":"Chwan Ng AC, Freedman SB, Sindone AP: Autonomic abnormalities in congestive heart failure patients with sleep-disordered breathing. J Card Fail 2007, 13:395\u2013400.","journal-title":"J Card Fail"},{"key":"53_CR64","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1513\/pats.200708-143MG","volume":"5","author":"J.M. Golbin","year":"2008","unstructured":"Golbin JM, Somers VK, Caples SM: Obstructive sleep apnea, cardiovascular disease, and pulmonary hypertension. Proc Am Thorac Soc 2008, 5:200\u2013206.","journal-title":"Proc Am Thorac Soc"},{"key":"53_CR65","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/ajrccm.163.1.2001008","volume":"163","author":"E. Shahar","year":"2001","unstructured":"Shahar E, Whitney CW, Redline S, et al.: Sleep-disordered breathing and cardiovascular disease cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001, 163:19\u201325.","journal-title":"Am J Respir Crit Care Med"},{"key":"53_CR66","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejheart.2006.08.003","volume":"9","author":"O. Oldenburg","year":"2007","unstructured":"Oldenburg O, Lamp B, Faber L, et al.: Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. Eur J Heart Fail 2007, 9:251\u2013257.","journal-title":"Eur J Heart Fail"},{"key":"53_CR67","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1183\/09031936.00037106","volume":"29","author":"R. Schulz","year":"2007","unstructured":"Schulz R, Blau A, Borgel J, et al.: Sleep apnoea in heart failure. Eur Respir J 2007, 29:1201\u20131205.","journal-title":"Eur Respir J"},{"key":"53_CR68","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.amjcard.2006.12.052","volume":"99","author":"M.E. Otto","year":"2007","unstructured":"Otto ME, Belohlavek M, Romero-Corral A, et al.: Comparison of cardiac structural and functional changes in obese otherwise healthy adults with versus without obstructive sleep apnea. Am J Cardiol 2007, 99:1298\u20131302.","journal-title":"Am J Cardiol"},{"key":"53_CR69","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1164\/ajrccm.164.6.2001092","volume":"164","author":"U.C. Guidry","year":"2001","unstructured":"Guidry UC, Mendes LA, Evans JC, et al.: Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. Am J Respir Crit Care Med 2001, 164:933\u2013938.","journal-title":"Am J Respir Crit Care Med"},{"key":"53_CR70","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1183\/09031936.96.09040787","volume":"9","author":"R. Kessler","year":"1996","unstructured":"Kessler R, Chaouat A, Weitzenblum E, et al.: Pulmonary hypertension in the obstructive sleep apnoea syndrome: prevalence, causes and therapeutic consequences. Eur Resp J 1996, 9:787\u2013794.","journal-title":"Eur Resp J"},{"key":"53_CR71","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1093\/eurheartj\/ehi807","volume":"27","author":"M.A. Arias","year":"2006","unstructured":"Arias MA, Garcia-Rio F, Alonso-Fernandez A, et al.: Pulmonary hypertension in obstructive sleep apnoea: effects of continuous positive airway pressure: a randomized, controlled cross-over study. Eur Heart J 2006, 27:1106\u20131113.","journal-title":"Eur Heart J"},{"key":"53_CR72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1164\/ajrccm.165.2.2010092","volume":"165","author":"D. Sajkov","year":"2002","unstructured":"Sajkov D, Wang T, Saunders NA, et al.: Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. Am J Respir Crit Care Med 2002, 165:152\u2013158.","journal-title":"Am J Respir Crit Care Med"},{"key":"53_CR73","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.jacc.2006.12.046","volume":"49","author":"H. Wang","year":"2007","unstructured":"Wang H, Parker JD, Newton GE, et al.: Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 2007, 49:1625\u20131631.","journal-title":"J Am Coll Cardiol"},{"key":"53_CR74","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1001\/jama.291.16.2013","volume":"291","author":"T. Young","year":"2004","unstructured":"Young T, Skatrud J, Peppard PE: Risk factors for obstructive sleep apnea in adults. JAMA 2004, 291:2013\u20132016.","journal-title":"JAMA"},{"key":"53_CR75","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1164\/ajrccm.152.2.7633695","volume":"152","author":"M.T. Naughton","year":"1995","unstructured":"Naughton MT, Benard DC, Liu PP, et al.: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995, 152:473\u2013479.","journal-title":"Am J Respir Crit Care Med"},{"key":"53_CR76","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1161\/01.CIR.0000056520.17353.4F","volume":"107","author":"D. Mansfield","year":"2003","unstructured":"Mansfield D, Kaye DM, Brunner La Rocca H, et al.: Raised sympathetic nerve activity in heart failure and central sleep apnea is due to heart failure severity. Circulation 2003, 107:1396\u20131400.","journal-title":"Circulation"},{"key":"53_CR77","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20070172","volume":"114","author":"M.P. Gilman","year":"2008","unstructured":"Gilman MP, Floras JS, Usui K, et al.: Continuous positive airway pressure increases heart rate variability in heart failure patients with obstructive sleep apnoea. Clin Sci (Lond) 2008, 114:243\u2013249.","journal-title":"Clin Sci (Lond)"},{"key":"53_CR78","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/01.CIR.99.12.1574","volume":"99","author":"P. Solin","year":"1999","unstructured":"Solin P, Bergin P, Richardson M, et al.: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999, 99:1574\u20131579.","journal-title":"Circulation"},{"key":"53_CR79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1152\/japplphysiol.00698.2005","volume":"104","author":"J.B. Snow","year":"2008","unstructured":"Snow JB, Kitzis V, Norton CE, et al.: Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity. J Appl Physiol 2008, 104:110\u2013118.","journal-title":"J Appl Physiol"},{"key":"53_CR80","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1161\/CIRCULATIONAHA.106.683482","volume":"115","author":"M. Arzt","year":"2007","unstructured":"Arzt M, Floras JS, Logan AG, et al.: Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients With Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007, 115:3173\u20133180.","journal-title":"Circulation"},{"key":"53_CR81","doi-asserted-by":"crossref","unstructured":"Matthews JC, Pagani FD, Aaronson KD: Right ventricular failure risk score: a preoperative prediction tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008 (in press).","DOI":"10.1016\/j.healun.2006.11.140"}],"container-title":["Current Treatment Options in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-008-0053-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11936-008-0053-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11936-008-0053-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T08:39:06Z","timestamp":1635151146000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11936-008-0053-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1007\/s11936-008-0053-6","relation":{},"ISSN":["1092-8464","1534-3189"],"issn-type":[{"value":"1092-8464","type":"print"},{"value":"1534-3189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}